REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 307 filers reported holding REPLIGEN CORP in Q4 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,204,000 | -29.0% | 134 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $35,489,000 | -8.4% | 134 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $38,724,000 | +44.8% | 134 | 0.0% | 0.02% | +45.5% |
| Q2 2021 | $26,749,000 | +29.2% | 134 | +24.1% | 0.01% | +10.0% |
| Q4 2020 | $20,696,000 | +29.9% | 108 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $15,934,000 | +19.4% | 108 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $13,350,000 | -12.5% | 108 | -31.6% | 0.01% | -33.3% |
| Q1 2020 | $15,253,000 | -28.0% | 158 | -31.0% | 0.01% | 0.0% |
| Q4 2019 | $21,183,000 | +30.9% | 229 | +8.5% | 0.01% | +20.0% |
| Q3 2019 | $16,182,000 | -10.8% | 211 | 0.0% | 0.01% | -9.1% |
| Q2 2019 | $18,135,000 | +45.5% | 211 | 0.0% | 0.01% | +57.1% |
| Q1 2019 | $12,466,000 | – | 211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |